The health ministry on Thursday disclosed the names of 6,916 hospitals and 17 medical suppliers believed to have stocked a hepatitis C-tainted blood product that caused one of the largest medical disasters in Japan's postwar history.
The ministry earlier had put the number of such institutions at 7,004, based on reports from Mitsubishi Pharma Corp., the successor to Green Cross Corp., which sold the U.S.-made coagulant known as fibrinogen.
Of the 6,933 groups listed, 6,611 have been contacted by the ministry and reported that they had stocked the coagulant.